So then if what you state that Resapp dx may be approved sometime in August this year then this will give clear indication of path toward Resapp data collection protocols for future US Adult trial that has been announced by RAP to commence this coming US cold weather starting around November 2019 .
I am happy with that.
I would like to see an update on patient recruitment numbers and target numbers for Blind Home OSAS sleep study.
And I expect to see results of Australian Adult blind data this week.
It was announced by RAP in October 2018 that this Home sleep study would be completed by end CY 2018.
We are now 3 months past that target date.
I appreciate the passion and dedication of the RAP team.
I wish Tony all the best for the RAP Partnering Presentations in Hong Kong and Shanghai this week. wow!
I think release of Australian Adult blind data and an up date on the Home sleep study enrollments and target number would be great news to announce at upcoming Hong Kong and Shanghai presentations.
Thanks Brian.
MB
- Forums
- ASX - By Stock
- Executing FDA Approval
So then if what you state that Resapp dx may be approved...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.6¢ |
Change
0.001(1.82%) |
Mkt cap ! n/a |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.6¢ | $240.9K | 4.194M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 361732 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 183839 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7475 | 0.072 |
1 | 11515 | 0.071 |
1 | 14000 | 0.070 |
2 | 55500 | 0.069 |
2 | 104700 | 0.068 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 14028 | 1 |
0.075 | 72547 | 4 |
0.076 | 368295 | 2 |
0.077 | 230000 | 2 |
0.079 | 50000 | 1 |
Last trade - 14.08pm 22/04/2021 (20 minute delay) ? |
RAP (ASX) Chart |
Day chart unavailable